| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.535 | 17.753 | 10.632 | 9.651 | 5.315 | 176 | 14.448 | 56.804 | 85.870 | 35.450 |
| Total Income - EUR | 16.535 | 17.754 | 10.742 | 9.652 | 5.315 | 176 | 14.594 | 57.822 | 85.894 | 35.450 |
| Total Expenses - EUR | 12.762 | 7.850 | 8.505 | 13.981 | 6.976 | 527 | 13.747 | 47.125 | 79.542 | 49.752 |
| Gross Profit/Loss - EUR | 3.773 | 9.903 | 2.237 | -4.329 | -1.660 | -351 | 847 | 10.697 | 6.352 | -14.301 |
| Net Profit/Loss - EUR | 3.277 | 9.371 | 2.032 | -4.425 | -1.764 | -356 | 476 | 9.994 | 5.596 | -14.613 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dezimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 164 | 0 | 124 | 79 | 35 | 0 | 0 | 2.028 | 1.516 | 1.005 |
| Current Assets | 38.033 | 50.382 | 50.867 | 41.660 | 37.900 | 36.406 | 32.846 | 27.194 | 30.029 | 18.247 |
| Inventories | 12.177 | 12.408 | 14.496 | 11.443 | 13.159 | 11.958 | 0 | 9.646 | 6.065 | 3.446 |
| Receivables | 22.133 | 24.485 | 22.530 | 19.918 | 13.697 | 13.541 | 22.815 | 10.728 | 15.004 | 11.849 |
| Cash | 3.723 | 13.489 | 13.842 | 10.298 | 11.044 | 10.907 | 10.032 | 6.820 | 8.960 | 2.952 |
| Shareholders Funds | 28.652 | 37.730 | 39.124 | 33.981 | 33.635 | 32.641 | 32.393 | 10.042 | 15.608 | 908 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.669 | 12.736 | 11.950 | 7.897 | 4.301 | 3.765 | 453 | 19.207 | 16.243 | 18.658 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4321 - 4321" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Dezimed Srl